0001179110-20-012216.txt : 20201223
0001179110-20-012216.hdr.sgml : 20201223
20201223160510
ACCESSION NUMBER: 0001179110-20-012216
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201221
FILED AS OF DATE: 20201223
DATE AS OF CHANGE: 20201223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glass Geoffrey Michael
CENTRAL INDEX KEY: 0001517718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 201412267
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BLVD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
edgar.xml
FORM 4 -
X0306
4
2020-12-21
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001517718
Glass Geoffrey Michael
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
1
0
0
0
ADSs
2020-12-21
5
G
0
E
18600
0
D
47100
D
ADSs
18600
I
By Trust
Stock Option (Right to Buy)
2.03
2020-12-21
5
G
0
E
60000
0
A
2029-08-07
ADSs
60000
0
D
Stock Option (Right to Buy)
2.03
2029-08-07
ADSs
60000
60000
I
By Trust
Stock Option (Right to Buy)
8.48
2020-12-21
5
G
0
E
42000
0
A
2030-08-07
ADSs
42000
0
D
Stock Option (Right to Buy)
8.48
2030-08-07
ADSs
42000
42000
I
By Trust
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
On December 21, 2020, the reporting person transferred 18,600 ADSs to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
On December 21, 2020, the reporting person transferred 60,000 options to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
Options become exercisable as to 20,000 ADSs on each of the first three anniversaries after the 08/07/2019 grant date.
On December 21, 2020, the reporting person transferred 42,000 options to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
Options become exercisable as to 14,000 ADSs on each of the first three anniversaries after the 08/07/2020 grant date.
/s/ Jerad Seurer, as attorney-in-fact
2020-12-23